The Senate approved a major bill to tackle the opioid crisis with a nearly unanimous vote.

The Coca-Cola Company admitted it is taking a hard look at the use of cannabis in drinks after reports emerged that the company was in talks to develop a health drink infused with cannabidiol, a compound from the cannabis plant.

CVS Health will allow self-funded insurers to exclude some drugs from coverage if the cost is too high. The policy has been met with criticism from the pharmaceutical industry, which argues CVS is dividing treatment at arbitrary values.

CVS Health’s $69 billion takeover of Aetna may soon be greenlit by the U.S. Department of Justice Antitrust Division, according to Reuters, which cited a source familiar with the matter.

The U.S. Department of Justice (DOJ) Antitrust Division has cleared the $67 billion acquisition of Express Scripts by Cigna.

As part of its Patients Over Paperwork initiative, CMS has proposed another round of “red tape” cuts for healthcare providers that could reduce some burdens and loosen regulations across healthcare settings.

Jefferson Health and Einstein Healthcare Network have reached a definitive agreement to merge after previously announcing their intentions in March.

The New England Journal of Medicine continues to refuse to retract an article after its lead author was accused of plagiarism and resigned amid an internal investigation, according to STAT. On Sept. 13, H. Gilbert Welch, MD, MPH, stepped down as a professor with the Dartmouth Institute in Lebanon, New Hampshire, after the university found he plagiarized two colleagues in a paper published in NEJM in 2016.